- Atlas
- Medicine & Health
- Vaccinology
Vaccinology
Vaccinology is the science of making the immune system remember.
11 frameworks, from 1500 to today · Immunology · Medicine & Health
- Variolation 1500-1800
- Jennerian vaccination 1796-1880
- Germ-theory vaccine program 1879-1930
- Killed and live-attenuated vaccine platforms 1920-Present
- Immunologic adjuvant 1926-Present
- Clonal selection 1957-Present
- Eradication and ring vaccination 1967-Present
- Correlates of immunity 1970-Present
- Subunit and conjugate vaccine design 1980-Present
- Reverse vaccinology 1995-Present
- Platform technology 2010-Present
Overview
Vaccinology is the science of making the immune system remember1. Its practitioners take a pathogen, or a piece of one, or the instructions to build one, and turn it into something that teaches a body to defend itself without first suffering the disease. What is at stake is unusual among medical fields: vaccines are given to healthy people, often to every child born, so the standards of evidence and safety are set higher than almost anywhere else in medicine. The field's history is a long argument about two questions that keep returning in new form—what part of a microbe should the immune system be shown, and how can we prove that showing it actually protects?
Variolation: Deliberate Infection Before Vaccination
For centuries smallpox was among the most feared diseases, killing perhaps a third of those it infected and scarring or blinding many survivors. The first deliberate defense was variolation: introducing material from a smallpox lesion—dried scabs blown into the nose, or pus scratched into the skin—to produce a milder infection that conferred lifelong protection. The practice is documented in China by the sixteenth century and in India and the Ottoman world in the same broad era; its practitioners did not know what a virus was, but they had observed that survivors rarely caught smallpox twice. The method worked often enough to spread, but it carried a real risk of full-blown smallpox and of seeding outbreaks. Variolation was the first demonstration that immunity could be manufactured rather than waited for, and it set the template: expose the body to the disease on purpose, under controlled conditions.
Jenner and the Cowpox Turn
The decisive change came from observation of a different disease. In 1796 the English physician Edward Jenner, building on rural lore that milkmaids who caught cowpox were spared smallpox, inoculated a boy with cowpox material and then exposed him to smallpox—the child did not fall ill123. Jenner published his account in 179814. The innovation was not the idea of deliberate inoculation but the choice of a different, safer agent: cowpox (vaccinia) produced a mild infection and still protected15. The word vaccine, from the Latin vacca for cow, dates from this work12. Jennerian vaccination spread across Europe and the world within a generation, and it introduced the field's central principle—that protection can be transferred from a related but harmless organism, not only from the disease itself.
Pasteur and the Germ-Theory Rebuild
For most of the nineteenth century vaccination meant smallpox alone6. The germ theory changed that by identifying specific microbes as causes of specific diseases, which made it possible to think about making a vaccine for any of them7. Louis Pasteur's work in the 1870s and 1880s supplied the key methods. In 1879–1880, studying chicken cholera, his team found that old cultures of the bacterium had lost virulence; birds given the weakened culture survived and resisted a fresh lethal dose. Pasteur generalized this into attenuation—deliberately weakening a pathogen so it immunizes without causing disease—and applied it to anthrax (1881) and rabies (1885). The rabies vaccine was especially striking because it was given after exposure and still worked8. Pasteur's program established the laboratory logic of vaccinology: isolate the agent, weaken or kill it, prove protection in animals, then in people.
Killed and Live-Attenuated Platforms
The early twentieth century turned Pasteur's principle into a set of standard manufacturing methods. Killed vaccines use pathogens inactivated by heat or chemicals (typhoid, cholera, and later pertussis and influenza); they are safe because the organism cannot replicate, but they tend to produce weaker, shorter-lived immunity and often need adjuvants or boosters19. Live-attenuated vaccines use weakened organisms that replicate enough to provoke a strong, durable response (BCG for tuberculosis, developed from 1921; yellow fever, 1930s; oral polio, 1960s). The trade-off is the field's recurring tension: live vaccines immunize better but carry a small risk, especially in the immunocompromised, while killed vaccines are safer but less potent19. The Salk inactivated polio vaccine (1955) and the Sabin live oral vaccine (early 1960s) made this choice a public argument in the 1950s and 1960s, and both remain in use.
Adjuvants: The Chemistry of "Danger"
Killed and subunit vaccines are often poorly immunogenic on their own, so vaccinology needed substances that amplify the response9. Adjuvants are such substances10. Aluminum salts (alum) were introduced in the 1920s and remained for decades the only adjuvant licensed for human use. Their mechanism was long obscure; the modern understanding is that adjuvants work in part by signaling danger to the innate immune system, which is what convinces the adaptive system to respond. The practical consequence is that adjuvant chemistry became a design discipline: oil-in-water emulsions, and later defined molecules that engage specific innate receptors, allowed vaccines to be tailored—stronger responses in the elderly, fewer doses, or a shift toward the kind of immunity a particular pathogen requires.
Clonal Selection and What Vaccination Actually Does
The theoretical grounding of vaccinology arrived with the clonal selection theory of immunity, developed by Niels Jerne, David Talmage, and Macfarlane Burnet in the 1950s. Its claim: each lymphocyte bears receptors of one specificity, and an antigen selects and expands the cells that fit it, producing clones of effector cells and long-lived memory cells. This explained, at the cellular level, why a vaccine works—it is a controlled encounter that leaves behind a population of memory cells6. It also reframed vaccine design as a problem of choosing the antigen that will select the right clones, and it made immunological memory the measurable goal of the field.
Eradication and Ring Vaccination
The mid-twentieth century showed that vaccination could do more than protect individuals: it could remove a disease from the world2. Smallpox eradication, declared by the World Health Organization in 1980, was the landmark23. The campaign combined mass vaccination with ring vaccination—identifying and vaccinating the contacts of each case to build a firewall around every outbreak—a strategy that proved decisive where mass coverage was hard to reach. The same logic, and the same ambition, drove the polio eradication program launched in 1988. The lesson was double-edged: eradication is possible when a vaccine is highly effective, the pathogen has no animal reservoir, and surveillance is strong; where those conditions fail, as with polio's persistence in a few regions, the campaign becomes a long war of attrition111.
Correlates of Protection: Proving That It Works
A vaccine's real test is whether it prevents disease, which requires large, long, expensive trials. Vaccinology therefore sought correlates of protection—measurable immune markers, such as a threshold antibody level, that predict protection without waiting for disease12. The concept is powerful and dangerous: a correlate is only as good as the evidence behind it, and a marker that correlates in one population may not in another12. The field's modern practice is to combine efficacy trials with immunological measurement, so that a correlate can be validated and then used to license or reformulate vaccines faster.
Molecular Design: Subunits and Conjugates
From the 1970s, recombinant DNA and protein chemistry let vaccinologists stop using whole organisms and design subunit vaccines from defined antigens—single proteins or polysaccharides. The conjugate vaccine was the model success: Haemophilus influenzae type b (Hib) bacteria are coated in a polysaccharide that the immature infant immune system responds to poorly, so researchers chemically linked (conjugated) the polysaccharide to a carrier protein, which recruited T-cell help and made the vaccine work in infants. Hib conjugate vaccines, introduced in the late 1980s and 1990s, drove invasive Hib disease down dramatically, and the same approach produced effective pneumococcal and meningococcal conjugate vaccines. The principle—that the form in which an antigen is presented determines the response—became central.
Reverse Vaccinology and Platform Technology
The genomic era inverted the old workflow13. Instead of growing a pathogen and testing its components, reverse vaccinology begins with the pathogen's genome, predicts which proteins are likely surface-exposed and immunogenic, and tests those candidates13. The approach was pioneered for Neisseria meningitidis serogroup B in the 1990s and 2000s, yielding a vaccine licensed in 2013 for a strain that conventional methods had failed to crack. More recently, platform technologies—using one manufacturing backbone for many vaccines—have compressed development. The mRNA vaccines against COVID-19, deployed from late 2020, are the clearest case: the platform delivers genetic instructions rather than the antigen itself, and it could be reprogrammed quickly as the virus changed. The same period saw viral-vector and protein-subunit platforms scaled at unprecedented speed.
The Present
Vaccinology today runs on several parallel tracks that descend directly from this history: live-attenuated and killed whole-organism vaccines for many diseases; subunit and conjugate design built on molecular antigen selection; adjuvants engineered to steer the immune response; and the newer genetic platforms1. The open questions are the old ones in new clothes—how to induce durable immunity at mucosal surfaces, how to protect the immunocompromised and the very young, how to validate correlates of protection fast enough to keep pace with a pathogen, and how to design vaccines against pathogens, like HIV and tuberculosis, whose immune evasion has so far defeated every platform the field has built.
References
- Vaccine (introduction, Effectiveness, History, Heterotypic, Inactivated, Attenuated, Types), Wikipedia
- Smallpox vaccine, Wikipedia
- Cowpox, Wikipedia
- Edward Jenner, Wikipedia
- Attenuated vaccine (History), Wikipedia
- Immunization (History, introduction), Wikipedia
- Germ theory of disease, Wikipedia
- Rabies vaccine, Wikipedia
- Inactivated vaccine, Wikipedia
- Immunologic adjuvant, Wikipedia
- Eradication of infectious diseases, Wikipedia
- Correlates of immunity, Wikipedia
- Reverse vaccinology (History, introduction), Wikipedia
The frameworks of Vaccinology
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1500-1800
- 1796-1880
Jennerian vaccination
Can a harmless related organism confer protection?
- 1879-1930
Germ-theory vaccine program
Can any pathogen be weakened into a vaccine?
- 1920-Present
Killed and live-attenuated vaccine platforms
Should a vaccine use killed or weakened organisms?
- 1926-Present
- 1957-Present
- 1967-Present
Eradication and ring vaccination
Can a disease be removed from the world?
- 1970-Present
Correlates of immunity
Which immune measurement predicts real protection?
- 1980-Present
Subunit and conjugate vaccine design
Which piece of a microbe should be shown to the immune system?
- 1995-Present
- 2010-Present
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Jennerian vaccination grew out of Variolation
Jenner built directly on variolation's practice of deliberate inoculation, but substituted cowpox for smallpox material after rural observation that milkmaids were spared. The 1796 inoculation of James Phipps and the 1798 publication turned variolation's template into vaccination with a safer agent.
Carried by Edward Jenner; An Inquiry into the Causes and Effects of the Variolae Vaccinae (1798).
Germ-theory vaccine program grew out of Jennerian vaccination
Pasteur generalized Jenner's principle that a related or weakened agent can immunize, extending it beyond smallpox to any pathogen once germ theory identified specific microbes. His attenuation of chicken cholera (1879–80), anthrax (1881) and rabies (1885) established the laboratory program of isolating, weakening and testing agents.
Carried by Louis Pasteur.
Killed and live-attenuated vaccine platforms grew out of Germ-theory vaccine program
The killed and live-attenuated platforms industrialized Pasteur's attenuation principle into standard manufacturing methods: heat- or chemical-inactivated organisms and deliberately weakened live strains. BCG (from 1921), yellow fever vaccine (1930s) and the Salk and Sabin polio vaccines (1955, early 1960s) carried the program forward.
Carried by BCG (1921); Salk inactivated polio vaccine (1955); Sabin oral polio vaccine (early 1960s).
Immunologic adjuvant grew out of Killed and live-attenuated vaccine platforms
Killed vaccines proved poorly immunogenic on their own, creating the practical need for substances that amplify the response. Aluminum salts were introduced in the 1920s as the first licensed human adjuvant, making adjuvant chemistry a design discipline within vaccine manufacturing.
Carried by Alexander Glenny.
Eradication and ring vaccination grew out of Killed and live-attenuated vaccine platforms
Smallpox eradication depended on the existing live vaccinia vaccine and on mass vaccination campaigns built on the killed/live platform tradition. Ring vaccination was added as a tactical refinement of that vaccine-based campaign, using the same vaccine to firewall outbreaks.
Carried by World Health Organization smallpox eradication campaign.
Subunit and conjugate vaccine design grew out of Killed and live-attenuated vaccine platforms
Submit and conjugate design grew out of the whole-organism platforms by replacing them with defined antigens, once recombinant DNA and protein chemistry made isolated components practical. The Hib conjugate vaccine (late 1980s) showed that presenting a purified polysaccharide on a carrier protein could recruit T-cell help.
Carried by Hib conjugate vaccine (late 1980s).
Correlates of immunity influenced by Clonal selection
Clonal selection made immunological memory a cellular, measurable entity—expanded clones of memory cells—which gave vaccinology a theoretical basis for seeking immune markers that predict protection. The search for correlates of immunity presupposes that a quantifiable adaptive response underlies protection.
Carried by Macfarlane Burnet.
Reverse vaccinology grew out of Subunit and conjugate vaccine design
Reverse vaccinology extended subunit design by choosing candidate antigens from the genome rather than from cultured organism components. The meningococcal serogroup B vaccine project of the 1990s and 2000s used predicted surface proteins as subunit candidates when conventional methods had failed.
Carried by Rino Rappuoli.
Platform technology grew out of Reverse vaccinology
Platform technology generalized reverse vaccinology's informatics-driven, antigen-defined approach into reusable manufacturing backbones that can be redirected to new pathogens. The mRNA vaccines against COVID-19 are the clearest case of a single platform compressed across many targets.
Subunit and conjugate vaccine design influenced by Immunologic adjuvant
Adjuvant chemistry taught vaccinologists that the form of antigen presentation determines the immune response, a lesson carried into subunit and conjugate design. Conjugate vaccines exploit the same principle—that linking an antigen to a carrier changes how the immune system sees it.
Beyond the field
Where Vaccinology's ideas came from in other fields, and what they led to there: the strongest 12 of 46 links.
Variolation influenced Vaccinology in Infectious Diseases
Variolation supplied the model and much of the practice Jenner built on: deliberate inoculation of smallpox matter to induce mild disease, which he modified by substituting cowpox lymph.
Carried by Edward Jenner.
Variolation influenced Vaccination and Acquired Immunity in Immunology
Variolation, the deliberate inoculation of smallpox material, supplied the practical model and much of the popular debate that Jenner built on when he substituted cowpox lymph in 1796. The move from variolation to vaccination was a direct modification of the earlier practice.
Carried by Edward Jenner; An Inquiry into the Causes and Effects of the Variolae Vaccinae (1798).
Variolation led to Vaccination in Immunotherapy
Jenner's 1796 cowpox vaccination built directly on the practice of variolation, using the same inoculation logic but substituting cowpox material; variolation's demonstrated protection against smallpox was the model vaccination refined.
Carried by Edward Jenner.
Jennerian vaccination led to Vaccination and Acquired Immunity in Immunology
The idea that vaccination confers acquired immunity grew directly out of Jenner's 1796 cowpox inoculation and its subsequent testing; later work on acquired immunity took vaccination as its founding case.
Carried by Edward Jenner; An Inquiry into the Causes and Effects of the Variolae Vaccinae (1798).
Germ-theory vaccine program influenced by Germ theory of disease in Epidemiology
Pasteur's germ-theory work, above all the attenuation of chicken cholera and anthrax in 1879-1881, turned the germ theory of disease into a vaccine programme by showing that cultured pathogens could be weakened and used to protect. The vaccine program is the direct application and extension of germ-theory reasoning.
Carried by Louis Pasteur; Robert Koch.
Germ-theory vaccine program influenced by Germ theory of disease in Infectious Diseases
The germ theory of disease, established by Pasteur and Koch in the 1860s-1880s, supplied the causal framework that made deliberate vaccine development possible. The vaccine programme took the identification of specific pathogens as its starting point.
Carried by Louis Pasteur; Robert Koch.
Killed and live-attenuated vaccine platforms influenced Vaccinology and Viral Disease Control in Virology
Killed and live-attenuated vaccine platforms supplied the technical options used in viral disease control, notably Salk's formalin-inactivated poliovirus vaccine and Sabin's attenuated strains. The platform concepts of inactivation and attenuation were carried directly into viral vaccine programmes.
Carried by Jonas Salk; Albert Sabin.
Killed and live-attenuated vaccine platforms influenced Vaccine in Aquatic Health
Fish vaccines were built on the killed and live-attenuated vaccine platforms developed for human and veterinary medicine, adopting their inactivation and attenuation methods directly.
Immunologic adjuvant grew out of Vaccination in Immunotherapy
Adjuvants arose directly from vaccination practice, as a means of strengthening the response to vaccines. The technique is a refinement within the older practice.
Carried by Gaston Ramon.
Eradication and ring vaccination grew out of Vaccinology in Infectious Diseases
Eradication and ring vaccination are a branch of vaccinology: they apply vaccine immunology at population scale, using coverage thresholds and targeted vaccination of contacts. The framework grew directly out of the vaccine science and programme practice of the preceding decades.
Correlates of immunity influenced by Humoral immunity in Immunology
Early humoral immunity research established antibody as the mediator of vaccine-induced protection and developed the serological techniques for measuring it. Correlates of immunity are the later, quantitative application of that antibody-centred view.
Correlates of immunity grew out of Vaccinology in Infectious Diseases
Correlates of immunity are a branch of vaccinology, asking which measurable immune responses predict protection after vaccination. The concept grew out of vaccine evaluation practice and remains part of the vaccinological programme.

Vaccinology is a planet in Nousfarer
Its city has a tower for each of these 11 frameworks. Land, walk in, and climb one concept at a time.
Land on VaccinologyRelated fields
Fields its ideas are linked to
- Infectious Diseases 8 links
- Immunology 8 links
- Virology 8 links
- Immunotherapy 5 links
- Fundamental Immunology 4 links
- Pediatric Infectious Diseases 3 links
- Aquatic Health 2 links
- Host Pathogen Immunology 2 links
- Epidemiology 1 link
- Clinical Immunology 1 link
- Immunogenetics 1 link
- Tumor Immunology 1 link